Twitter Beğeni Hilesi

Congratulations to David Lillicrap for receiving the 2024 ISTH Roberts Award for his lifetime of dedication and contributions to the ISTH #ISTH2024

Dr. Marc Carrier gave an excellent pitch to dragons 🐉 to ask for support quest for prevention of catheter associated thrombosis in cancer patients at INVENT-VTE Dragon’s Den #ISTH2024 Please vote for TRIM-Line!!

Dr. Nicola Potere reported that older age, low BMI, thrombocytopenia and renal impairment are associated with decision to use low dose DOAC for secondary prevention in patient with VTE. No difference in recurrent VTE or major bleeding between the two groups at #ISTH2024

Dr. Deborah Siegal reported the results of the VVIRTUOSO prospective cohort study. Symptomatic VTE is rare following hospitalization with COVID infection (0.9% (0.3-2.18 at 90 days)) and below threshold to evaluate thromboprophylaxis #ISTH2024 CanVECTOR Network Thrombosis Canada INVENT-VTE

Do you find tumor thrombus challenging ? Dr. Tzu-Fei Wang reporting that these patients are at high risk of recurrent thrombosis, bleeding and mortality independent of anticoagulation status (none, therapeutic or prophylactic). Future trials are needed!! #ISTH2024

Join us at the Thrombosis Canada 2024 Conference on Oct 26! Explore the latest in thrombosis management. Register today at thrombosiscanada.ca/2024Conference #thrombosis #medconference

🚨🆕 My latest publication in JACC Journals w/ Marc Carrier & Bram Rochwerg uses the case of anticoagulants for cancer-associated #VTE to stress the importance of GRADEing the certainty of evidence when interpreting findings from a network meta-analysis. jacc.org/doi/10.1016/j.…

🚀 The closing visits for the PARTUM Pilot trial are completed! 🎉 Excited for the next steps as we continue to explore whether low-dose aspirin can safely prevent postpartum VTE in women at increased risk. Stay tuned for more updates! PARTUMtrial Jennifer Donnelly Fionnuala Ní Áinle

Thank you Professor Leslie Skeith for your leadership in the international PARTUMtrial!

Narrative review explores how to manage use of DOACs—apixaban, rivaroxaban, edoxaban, and dabigatran—in patients undergoing surgical and nonsurgical procedures to decrease risks of bleeding and thromboembolism. ja.ma/4fIm1hL

Great review on perioperative managent of DOAC treated patients by Dr Douketis and Alex Spyropoulos from JAMA

Comprehensive Review Article on #DOAC #periop management: Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review pubmed.ncbi.nlm.nih.gov/39133476/ North American Thrombosis Forum Anticoagulation Forum World Thrombosis Day Thrombosis UK CanVECTOR Network Thrombosis Canada Thrombosis, Leiden European Thrombosis & Haemostasis Alliance (ETHA)

Fionnuala Ní Áinle PARTUMtrial Thank you - what an amazing effort by many to finish the pilot PARTUMtrial! Marc Rodger Jennifer Donnelly A. Kinga Malinowski, MD Dr. Darine El-Chaar wee-shian chan Saskia Middeldorp and more! CanVECTOR Network INVENT-VTE

Congratulations to Dr. Patricia Liaw [Patricia Liaw], recipient of the 2024 CIHR-ICRH/CSATVB Distinguished Lecturer Award in Blood and Blood Vessel Sciences! Thank you to our award partner @CSATVB-SCATBV for their continued support. Learn more: cihr-irsc.gc.ca/e/51591.html

Thank you CIHR-ICRH | L'ISCR des IRSC and CSATVB for the recognition! 🇨🇦 I am grateful and humbled to receive this award. Special thanks to my mentors, colleagues, and trainees who have made this scientific journey possible! 🙏😊

Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study | Haematologica haematologica.org/article/view/h… Hot off the press! Our experience in outpatient management of symptomatic cancer-associated PE. A big thank you to co-authors. More to come!

Join us in Toronto for Thrombosis Care in 2024: Meeting Today's Challenges. Come for the education and enjoy the city while you are there. Register today at bit.ly/3AeeK9b Marc Carrier Deborah Siegal Tzu-Fei Wang Eddy Lang

CanVECTOR 2024 Annual Conference: Early bird rates ending soon; Travel awards still Available ! - mailchi.mp/856f9c6091c3/y…